MarketPeel
Insider Trading Intelligence
TH

Tage Honore

VNDA
DIRECTOR · VANDA PHARMACEUTICALS INC. · CIK 0001967946
FILING MIX · LIFETIME89%/11%
BUYS
8
SELLS
1
TOTAL VALUE
$240.9K
COMPANIES
1
ACTIVE SINCE
Mar 2023
HOLDINGS NOW
135,069
AVG SELL PX
$8.03
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Tage Honore, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+0.24%+0.58%-0.34%-0.34%
14d1+0.00%+6.50%-0.60%+7.11%+7.11%
30d1+100.00%-11.04%-3.75%-7.30%-7.30%
60d1+100.00%-15.46%+4.62%-20.08%-20.08%
90d1+100.00%-23.93%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VNDA · 135,069 shares · as of Jun 4, 2026
033,76767,535101,302135,069202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 1 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
41,600135,069Jun 4, 2026Jun 8, 2026View →
VNDA
VANDA PHARMACEUTICALS INC.
SALE
30,000$8.03$240.9K93,469Feb 23, 2026Feb 24, 2026View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
59,225123,469Jun 5, 2025Jun 9, 2025View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,52964,244May 17, 2024May 21, 2024View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
37,57837,578May 17, 2024May 21, 2024View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
33,96033,960Jun 8, 2023Jun 9, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,30743,715Jun 8, 2023Jun 9, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
26,40826,408Mar 15, 2023Mar 17, 2023View →
VNDA
VANDA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
51,27651,276Mar 15, 2023Mar 17, 2023View →
Other insiders · VNDA
Loading peer insiders…
About this filer
CIK 0001967946
ROLE
Director
PRIMARY
VNDA
COMPANIES
1
ACTIVE SINCE
Mar 2023
MARKETPEEL · /INSIDER/0001967946DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback